Adicet Bio, Inc.
ACETNASDAQHealthcare● Active
$7.22
$-0.04(-0.55%)
Market Cap$67494293
P/E Ratio—
52W High$17.44
52W Low$6.01
Adicet Bio, Inc. (ACET) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ACET · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.02B | $0.01B |
| Cost of Revenue | $0.01B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | ($0.01B) | $0.00B | $0.00B | $0.02B | $0.01B |
| Gross Margin %(computed) | — | — | — | 100.00% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $0.10B | $0.10B | $0.11B | $0.07B | $0.05B |
| G&A Expenses | $0.02B | $0.03B | $0.03B | $0.03B | $0.02B |
| Total Operating Expenses | $0.12B | $0.13B | $0.15B | $0.10B | $0.07B |
| Operating Income | ($0.12B) | ($0.13B) | ($0.15B) | ($0.07B) | ($0.06B) |
| Operating Margin %(computed) | — | — | — | -290.32% | -631.38% |
| Interest Income | $0.01B | $0.01B | $0.01B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.12B) | ($0.12B) | ($0.14B) | ($0.07B) | ($0.06B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | ($0.00B) |
| Net Income | ($0.12B) | ($0.12B) | ($0.14B) | ($0.07B) | ($0.06B) |
| Net Margin %(computed) | — | — | — | -279.27% | -637.19% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-16.95 | $-21.28 | $-52.96 | $-27.20 | $-32.00 |
| Wtd Avg Shares | 0.01B | 0.01B | 0.00B | 0.00B | 0.00B |
| EBITDA | ($0.12B) | ($0.11B) | ($0.14B) | ($0.06B) | ($0.06B) |
| EBITDA Margin %(computed) | — | — | — | -258.91% | -620.86% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · B
Explore more Adicet Bio, Inc. data
About Adicet Bio, Inc. (ACET) Income Statement
Adicet Bio, Inc. (ACET) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, ACET reported revenue of $0.00B, gross profit of ($0.01B) (gross margin —), and net income of ($0.12B) — a net profit margin of —.
Frequently asked questions
ACET · 4 questionsAdicet Bio, Inc. (ACET) reported revenue of $0.00B for 2025, down —% year-over-year.
ACET revenueACET salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09